| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0959-8049(96)00414-5 |
| P698 | PubMed publication ID | 9071895 |
| P2093 | author name string | Holland JC | |
| Kornblith AB | |||
| Batel PC | |||
| Batel-Copel LM | |||
| P2860 | cites work | The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology | Q29615701 |
| Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer | Q33488625 | ||
| Surgical treatment of spinal cord compression from epidural metastasis | Q39472379 | ||
| Effects of intrapleural mitoxantrone and mepacrine on malignant pleural effusion--a randomised study. | Q40677186 | ||
| Lessons learned from measuring health-related quality of life in oncology | Q40720847 | ||
| Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects | Q42229071 | ||
| Performance status assessment in cancer patients | Q43798214 | ||
| Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes | Q48793166 | ||
| Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy | Q48940351 | ||
| Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy. | Q53634846 | ||
| Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer | Q53637895 | ||
| Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer. | Q53639104 | ||
| Oral ondansetron in the prevention of chemotherapy-induced emesis in breast cancer patients. French Ondansetron Study Group. | Q53652839 | ||
| A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. | Q53949583 | ||
| ‘Tomudex’ (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia | Q61868345 | ||
| Risks and benefits of cisplatin in ovarian cancer. A quality-adjusted survival analysis | Q68420169 | ||
| Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation | Q70356145 | ||
| Evaluation of patients with advanced cancer using the Karnofsky performance status | Q71180436 | ||
| Karnofsky performance status revisited: reliability, validity, and guidelines | Q71277291 | ||
| Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study | Q72037799 | ||
| P433 | issue | 1 | |
| P921 | main subject | quality of life | Q13100823 |
| P304 | page(s) | 29-32 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | European Journal of Cancer | Q332260 |
| P1476 | title | Do oncologists have an increasing interest in the quality of life of their patients? A literature review of the last 15 years | |
| P478 | volume | 33 |
| Q28344321 | A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01) |
| Q44740157 | Cancer patients and the Internet: a survey of the 'Quality of Life' Working Groups of the Arbeitsgemeinschaft für Internistische Onkologie and the Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie |
| Q51020213 | Cognitive-behavioral intervention for distress in patients with melanoma: comparison with standard medical care and impact on quality of life |
| Q40179738 | Conducting routine fatigue assessments for use in clinical oncology practice: patient and provider perspectives |
| Q44320526 | Ethnic differences in quality of life among early breast and prostate cancer survivors |
| Q24813905 | Ethnic differential item functioning in the assessment of quality of life in cancer patients |
| Q33947861 | Follicular lymphomas--a review of treatment modalities. |
| Q34882054 | Functional status and the elderly cancer patient |
| Q36642218 | Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer |
| Q34028986 | Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. |
| Q36291299 | Measuring quality of life: impact of chemotherapy for advanced colorectal cancer. Experience from two recent large phase III trials |
| Q42117487 | Nutritional screening and early treatment of malnutrition in cancer patients |
| Q34277768 | Palliative medicine and medical oncology |
| Q33328094 | Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer |
| Q53301946 | Predictors of quality of life in newly diagnosed melanoma and breast cancer patients. |
| Q34319606 | Quality of life as an outcome in clinical trials and cancer care: a primer for surgeons |
| Q34249655 | Quality of life as an outcome measure in surgical oncology. |
| Q53521867 | The standard of reporting of health-related quality of life in clinical cancer trials. |
Search more.